Janney Montgomery Scott’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,170
| Closed | -$746K | – | 2669 |
|
|
2024
Q4 | $746K | Buy |
3,170
+19
| +0.6% | +$4.47K | ﹤0.01% | 1746 |
|
|
2024
Q3 | $867K | Sell |
3,151
-6
| -0.2% | -$1.65K | ﹤0.01% | 1601 |
|
|
2024
Q2 | $767K | Buy |
3,157
+382
| +14% | +$92.8K | ﹤0.01% | 1600 |
|
|
2024
Q1 | $415K | Buy |
2,775
+892
| +47% | +$133K | ﹤0.01% | 2120 |
|
|
2023
Q4 | $360K | Buy |
+1,883
| New | +$360K | ﹤0.01% | 2114 |
|
|
2023
Q1 | – | Sell |
-1,051
| Closed | -$250K | – | 2485 |
|
|
2022
Q4 | $250K | Buy |
+1,051
| New | +$250K | ﹤0.01% | 2241 |
|
|
2022
Q3 | – | Sell |
-2,671
| Closed | -$380K | – | 2492 |
|
|
2022
Q2 | $380K | Buy |
+2,671
| New | +$380K | ﹤0.01% | 1763 |
|
|
2018
Q1 | – | Sell |
-1,577
| Closed | -$200K | – | 1936 |
|
|
2017
Q4 | $200K | Buy |
+1,577
| New | +$200K | ﹤0.01% | 1805 |
|
|
2016
Q1 | – | Sell |
-2,371
| Closed | -$223K | – | 1267 |
|
|
2015
Q4 | $223K | Buy |
+2,371
| New | +$223K | 0.01% | 1174 |
|
|
2015
Q3 | – | Sell |
-3,274
| Closed | -$392K | – | 1388 |
|
|
2015
Q2 | $392K | Buy |
3,274
+881
| +37% | +$106K | 0.01% | 1327 |
|
|
2015
Q1 | $250K | Buy |
+2,393
| New | +$250K | ﹤0.01% | 1911 |
|